Screening Archives - Page 2 of 9

Systematic review and meta-analysis of prognostic characteristics for breast cancers in populations with digital vs film mammography indicate the transition may have increased both early detection and overdiagnosis – Rachel Farber et al.

Lucia Marcello2024-06-03T15:58:10+10:00Breast cancer, Cancer, Imaging, Overdiagnosis, Publications, Screening, Women's health|

Film mammography has been replaced by digital mammography in breast screening programs globally. This led to a small increase in the rate of detection, but whether the detection of clinically important cancers increased is uncertain. We aimed to assess the impact on tumor characteristics of [...]

Factors influencing the time to diagnosis and treatment of breast cancer among women in low- and middle-income countries: A systematic review – Ranjeeta Subedi et al.

Lucia Marcello2024-04-10T17:24:54+10:00Breast cancer, Cancer, Insurance, Publications, Screening, Treatment, Underdiagnosis, Women's health|

Shorter time from symptoms recognition to diagnosis and timely treatment would be expected to improve the survival of patients with breast cancer (BC). This review identifies and summarizes evidence on time to diagnosis and treatment, and associated factors to inform an improved BC care pathways [...]

Breast Cancer Stage and Size Detected with Film versus Digital Mammography in New South Wales, Australia: A Population-Based Study Using Routinely Collected Data – Rachel Farber et al.

Lucia Marcello2024-04-07T16:18:13+10:00Breast cancer, Cancer, Imaging, Overdiagnosis, Publications, Screening|

Digital mammography has replaced film mammography in breast screening programs globally, including Australia. This led to an increase in the rate of detection, but whether there was increased detection of clinically important cancers is uncertain. In this population-wide retrospective cohort study in New South Wales, [...]

Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial – Nehmat Houssami et al.

Lucia Marcello2024-04-07T15:49:03+10:00Breast cancer, Breast density, Cancer, Imaging, Overdiagnosis, Publications, Screening|

Digital breast tomosynthesis (DBT) for breast cancer screening has been shown in international trials to increase cancer detection compared with mammography; however, results have varied across screening settings, and currently there is limited and conflicting evidence on interval cancer rates (a surrogate for screening effectiveness). [...]

Randomized Trial of Information for Older Women About Cessation of Breast Cancer Screening Invitations – Jenna Smith et al.

Lucia Marcello2024-04-07T15:44:27+10:00Ageing, Breast cancer, Cancer, Decision aids, Health literacy, Overdiagnosis, Publications, Screening, Shared decision making, Women's health|

Older women receive no information about why Australia’s breast screening program (BreastScreen) invitations cease after 74 years. We tested how providing older women with the rationale for breast screening cessation impacted informed choice (adequate knowledge; screening attitudes aligned with intention).

Health benefits and harms of mammography screening in older women (75+ years)—a systematic review – Erin Mathieu et al.

Lucia Marcello2024-04-07T15:40:26+10:00Ageing, Breast cancer, Cancer, Overdiagnosis, Overtesting, Publications, Screening, Women's health|

There is little evidence on the balance between potential benefits and harms of mammography screening in women 75 years and older. The aim of this systematic review was to synthesise the evidence on the outcomes of mammography screening in women aged 75 years and older.

Benefits and harms of prostate specific antigen testing according to Australian guidelines – Michael Caruana et al.

Lucia Marcello2024-04-07T12:52:52+10:00Cancer, Overdiagnosis, Prostate cancer, Publications, Risk, Screening, Tests|

Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide to undergo regular testing, should be offered testing every 2 years from 50 to 69 years. This [...]

Gestational diabetes mellitus screening and diagnosis criteria before and during the COVID-19 pandemic: a retrospective pre–post study – Paul P Glasziou & Jenny A Doust

Lucia Marcello2024-04-05T15:49:44+11:00COVID-19, Diabetes, Disease labels, Gestational diabetes, Overdiagnosis, Publications, Screening, Women's health|

To the Editor: Meloncelli and colleagues1 have provided clear evidence that a fasting venous plasma glucose (FVPG) assessment may be used to decrease the number of unnecessary oral glucose tolerance tests (OGTTs) for low risk women. This would be a very welcome step forward. However, it does [...]

Could nudges reduce health literacy disparities in CVD prevention? An experiment using alternative messages for CVD risk assessment screening – Michael Anthony Fajardo et al.

Lucia Marcello2024-04-05T14:58:38+11:00Cardiovascular disease, General Practice, Health literacy, Publications, Risk, Screening|

This study aimed to test different SMS messages inviting patients for a Heart Health Check with their GP. We also assessed how health literacy moderated these effects, to inform an Australian CVD risk screening program. Specifically, we tested a control message used in a previous [...]

‘Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives – Didu S. Kariyawasam et al.

Lucia Marcello2024-04-05T14:50:00+11:00Ethical considerations, Genetic testing, Genomics, Health policy, Publications, Risk, Screening|

Newborn bloodspot screening is a well-established population health initiative that detects serious, childhood-onset, treatable conditions to improve health outcomes. With genomic technologies advancing rapidly, many countries are actively discussing the introduction of genomic assays into newborn screening programs. While adding genomic testing to Australia’s newborn [...]

Screening

Staff Intranet